Biological age: what it measures, and why we chose Levine's PhenoAge
2. Oktober 2026

Two people turn 50 in the same week. One runs half marathons, sleeps well, and has the blood work of a 40-year-old. The other has quietly developed slightly elevated blood sugar, a raised CRP signaling low-grade inflammation, and early signs of declining kidney function, and has no idea. Their chronological age is identical. Their biological age is not.
Chronological age counts the years since you were born. Biological age estimates how far your body has actually traveled along the aging process. The two can differ by ten years or more, in either direction, and the gap between them predicts health outcomes better than the number on your passport.
In Switzerland, life expectancy at birth reached 81.6 years for men and 85.4 years for women in 2022, among the highest in the world. Across the EU, people can expect on average about 63 years free from activity limitations. The interesting question is no longer how long we live. It is how much of that time we spend healthy. Biological age is one of the first tools that tries to put a number on it.
What biological age actually means
Aging is a biological process, and biology leaves traces. Cells accumulate damage. Proteins misfold. Inflammation ticks upward. Metabolism becomes less efficient. The chemical tags that control which genes are switched on and off, a system called epigenetics, drift in predictable ways.
A biological age test measures some of these traces and turns them into a single number. Different tests look at different traces, from DNA methylation to routine blood values, as the next section explains.
With a blood-based clock such as PhenoAge (more on it below), a biological age of 44 at 50 means your blood profile carries the mortality risk typical of an average 44-year-old. A result of 56 means it looks like that of an average 56-year-old. The difference between the two numbers is called age acceleration. Positive means your body appears older than the calendar says, negative means younger. Because it is calculated from values that change with diet, activity, sleep and treatment, biological age is not fixed, and it can be measured again.

How biological age is measured
There is no single biological age. There are several methods, each built from different data and each answering a slightly different question. The three most established approaches are epigenetic clocks, blood biomarker clocks, and pace-of-aging measures.
Epigenetic clocks
In 2013, the geneticist Steve Horvath showed that DNA methylation, the pattern of small chemical tags attached to DNA, changes so predictably with age that it could estimate a person's age from a tissue sample to within a few years. His original clock used 353 methylation sites and worked across almost every tissue type in the body.
Later clocks were trained differently. Rather than predicting chronological age, GrimAge (published in 2019) was trained to predict time to death, using methylation patterns that track smoking history and blood proteins. It predicts lifespan and age-related disease considerably better than first-generation clocks. Clocks like these are behind most consumer "biological age" kits, which typically use a saliva sample or a finger-prick blood spot.
Blood biomarker clocks
You do not need a methylation array to estimate biological age. In 2018, Morgan Levine and colleagues developed PhenoAge, a measure built from nine routine clinical biomarkers plus chronological age: albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, mean cell volume, red cell distribution width, alkaline phosphatase, and white blood cell count. All nine appear in an ordinary blood test. Rather than training their model to guess a person's age, Levine's team trained it on what ultimately matters: who went on to develop disease and who died over the following years, in a cohort of nearly 10,000 US adults (NHANES III). The result, Phenotypic Age, expresses that risk as an age. It was then validated in an independent group of US adults, where it predicted all-cause mortality and age-related disease better than chronological age alone. Only in a second step did the researchers build a DNA methylation version (DNAm PhenoAge) trained to reproduce this blood-based score. The blood version stands on its own: it is a measure of risk, not a proxy for your DNA.
The appeal is obvious. The inputs are cheap, standardized, and already familiar to any physician. What we see at Ahead Health is that the components of a biomarker-based clock, including inflammation, kidney function, glucose regulation, and red cell indices, are exactly the values people most want to understand once they see them in context. That is why biological age is included in every Ahead blood check-up rather than sold as a separate test.
Pace of aging
A third approach asks a different question. Instead of "how old does your body look right now," it asks "how fast is it aging." DunedinPACE, published in 2022, is a DNA methylation test trained on data from about 1,000 New Zealanders followed from birth, whose organ systems were measured repeatedly across two decades. The result is expressed as a rate: 1.0 means aging one biological year per calendar year, 1.2 means 20 percent faster. A pace measure is more sensitive to recent changes, which makes it useful for tracking whether an intervention is working.
| Approach | What it measures | Sample | Best for |
| Epigenetic clock (Horvath, GrimAge) | DNA methylation patterns | Blood or saliva | Estimating current biological age, mortality risk |
| Blood biomarker clock (PhenoAge) | Mortality and disease risk, from nine routine blood values | Standard blood draw | Interpretable, integrated with a regular check-up |
| Pace of aging (DunedinPACE) | DNA methylation, trained on the rate of decline across organ systems | Blood | Tracking change over time |
What biological age can tell you
Across large studies, people whose biological age exceeds their chronological age have higher rates of cardiovascular disease, type 2 diabetes, cognitive decline, and death from any cause. GrimAge acceleration, for example, remains predictive of mortality after adjusting for traditional risk factors like blood pressure, cholesterol, and smoking status.
Here is the useful part: biological age summarizes many small signals into one. A slightly elevated CRP, a creeping fasting glucose, a low albumin: none of these would trigger action alone. Together, they may add up to a body aging faster than it should. Biological age makes that pattern visible.
It also moves. Studies of lifestyle change, including diet, exercise, and sleep, have reported reductions in measured biological age over months to a couple of years. The evidence is still maturing, and effect sizes vary between clocks, but the direction is consistent: the number responds.
What biological age cannot tell you
This is where honest perspective matters, because biological age is often sold with more confidence than the science supports.
It is not a diagnosis
A biological age of 58 at 50 says your body shows an aging pattern typical of someone older. It does not say why, and it does not say where. It cannot distinguish a fatty liver from arterial plaque from an early kidney issue.
The number has error bars
A 2022 study in Nature Aging found that technical noise alone produced deviations of up to nine years between replicate samples for six widely used epigenetic clocks. Newer computational methods reduce this to within about 1.5 years, but a single reading from a consumer test should be read as an estimate, not a verdict. Blood-based clocks are more stable between labs, but they react to your day: a cold or a recent infection can temporarily raise CRP and white blood cell count, and with them your result. That is why a single value is best interpreted by a physician and confirmed over time.
Different clocks disagree
The same person can be 45 on one clock and 52 on another. Each was trained on different data to predict different outcomes. Comparing your result to a friend's from a different provider is close to meaningless.
It cannot replace looking
The biomarkers that drive most biological age scores reflect what is circulating in your blood. They say nothing directly about the structure of your organs. An aneurysm, a kidney cyst, a suspicious liver lesion: these do not show up in a blood test or a methylation profile.
A number is a starting point, not a destination
The most useful way to think about biological age is as a summary statistic. It compresses a lot of information into one figure that is easy to understand and easy to track. Its weakness is the same as its strength: compression loses detail.
That is why, in preventive medicine, the value comes from combining methods. As Dr. Anna Erat, Chief Medical Officer at Ahead Health, puts it: "Nowadays in preventive medicine, we want to triangulate methods." A biological age score tells you the pace. A full biomarker panel tells you which systems are driving it. Imaging tells you whether that pace has already left structural marks. Blood is the software. MRI is the hardware. A single number, however elegant, is only one line of the report.
Standard Swiss check-ups under basic insurance (Grundversicherung) are built around symptoms and known risk factors. They often measure several of these markers individually, but nobody combines them into a biological age, and the check-up itself is usually ordered only when there is a reason to look. Nothing is wrong with that logic. It is simply reactive by design. A biological age measurement, repeated over time, is one of the clearer ways to make prevention proactive.

Biological age at Ahead Health
Every Ahead blood check-up includes your biological age, calculated with Levine's PhenoAge from your measured blood values. Ahead Advanced (CHF 2,490) combines a multi-parameter full-body MRI, with additional gender-specific imaging, and an advanced blood panel of more than 80 biomarkers. Your results are reviewed by Swiss board-certified physicians and delivered in a report that explains each value in context, with an optional consultation to walk through them.
Why we chose PhenoAge
There are dozens of biological age clocks. We chose PhenoAge for four reasons:
- It is built on outcomes. It was trained on disease and mortality, not on guessing your age, so the number reflects health risk.
- It is transparent. All nine inputs are standard lab values, so you can see exactly which markers pull your result up or down. If inflammation is the driver, the report shows it. If glucose regulation is, you see that too.
- It is reproducible. These markers are standardized across accredited labs, unlike epigenetic tests, whose results can vary between providers and repeat samples.
- It is trackable. The same markers are measured at every follow-up, so you can see whether the changes you make are moving the number.
No single number captures all of aging. PhenoAge does not reflect fitness, liver fat or insulin resistance, for example, which is why your physician reads it alongside the rest of your results.
Sources
- Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013;14:R115. https://genomebiology.biomedcentral.com/articles/10.1186/gb-2013-14-10-r115
- Levine ME, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10(4):573-591. https://pubmed.ncbi.nlm.nih.gov/29676998/
- Liu Z, et al. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLOS Medicine. 2018;15(12):e1002718. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002718
- Lu AT, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019;11(2):303-327. https://www.aging-us.com/article/101684
- Belsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420. https://elifesciences.org/articles/73420
- Higgins-Chen AT, et al. A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. Nature Aging. 2022;2:644-661. https://www.nature.com/articles/s43587-022-00248-2
- Moqri M, et al. Biomarkers of aging for the identification and evaluation of longevity interventions. Cell. 2023;186(18):3758-3775. https://pubmed.ncbi.nlm.nih.gov/37657418/
- Swiss Federal Statistical Office (BFS). Life expectancy. https://www.bfs.admin.ch/bfs/en/home/statistics/population/births-deaths/life-expectancy.html
- Eurostat. How many healthy life years can EU citizens expect? (August 2025). https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20250808-1

Doktor in MRI von der Universität Oxford. Chief Product Officer bei Ahead Health.
PhD in MRI von Oxford (Clarendon Scholar, 2 Patente). Head of Product bei DeepSpin mit Fokus auf portable MRI-Technologie. Erfahrung in GTM und datengetriebenem Pharmaberatung bei IQVIA sowie in Qualität und Regulierung für Medizinprodukte der Klasse III.
